These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 25329484)

  • 1. Evolving treatments in multiple myeloma patients with renal failure.
    Gozzetti A; Papini G; Candi V; Bocchia M
    Rev Recent Clin Trials; 2014; 9(4):276-9. PubMed ID: 25329484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thirteen treated of acute renal failure secondary to multiple myeloma with high cut off filters.
    Berni Wennekers A; Martín Azara MP; Dourdil Sahun V; Bergasa Liberal B; Ruiz Laiglesia JE; Vernet Perna P; Alvarez Lipe R
    Nefrologia; 2016; 36(4):418-26. PubMed ID: 27255910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New insights in the treatment of myeloma with renal failure].
    Moumas E; Hanf W; Desport E; Abraham J; Delbès S; Debiais C; Lacotte-Thierry L; Touchard G; Jaccard A; Fermand JP; Bridoux F
    Nephrol Ther; 2011 Nov; 7(6):457-66. PubMed ID: 21515102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended high cut-off haemodialysis for myeloma cast nephropathy in Auckland, 2008-2012.
    Tan J; Lam-Po-Tang M; Hutchison CA; de Zoysa JR
    Nephrology (Carlton); 2014 Jul; 19(7):432-5. PubMed ID: 24931113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is high cut-off hemodialysis effective in myeloma kidney?
    Finkel KW
    Semin Dial; 2014; 27(3):234-6. PubMed ID: 24666151
    [No Abstract]   [Full Text] [Related]  

  • 6. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
    Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
    J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney.
    Grima DT; Airia P; Attard C; Hutchison CA
    Curr Med Res Opin; 2011 Feb; 27(2):383-91. PubMed ID: 21175375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I
    Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA; Heyne N; Airia P; Schindler R; Zickler D; Cook M; Cockwell P; Grima D
    Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.
    Ward F; Dunne O; Crotty TB; Fennelly D; Watson A; Holian J
    Ir Med J; 2012 May; 105(5):148-9. PubMed ID: 22803494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
    Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal failure in multiple myeloma and its treatment].
    Ryšavá R
    Vnitr Lek; 2020; 66(7):425-431. PubMed ID: 33380121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide as a targeted therapy for multiple myeloma.
    Dan K
    Intern Med; 2003 Jul; 42(7):550-1. PubMed ID: 12879943
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple myeloma in end-stage renal disease.
    Penfield JG
    Semin Dial; 2006; 19(4):329-34. PubMed ID: 16893412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.
    Curti A; Schwarz A; Trachsler J; Tomonaga Y; Ambühl PM
    PLoS One; 2016; 11(7):e0159942. PubMed ID: 27467401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure.
    Dao K; Lu Y; Peer CJ; Figg WD; Stadelmann R; Burnier M; Buclin T; Kissling S
    Cancer Chemother Pharmacol; 2017 Jan; 79(1):215-218. PubMed ID: 27988790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.
    Huskey JL; Heilman RL; Khamash H; Fonseca R
    Transplantation; 2018 Dec; 102(12):1994-2001. PubMed ID: 30211830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal failure in multiple myeloma].
    Siciński A
    Pol Arch Med Wewn; 1986 Jan; 75(1):70-5. PubMed ID: 3725626
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved survival in multiple myeloma with renal failure.
    Wahlin A; Löfvenberg E; Holm J
    Acta Med Scand; 1987; 221(2):205-9. PubMed ID: 3591456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
    Zannetti BA; Zamagni E; Santostefano M; De Sanctis LB; Tacchetti P; Mancini E; Pantani L; Brioli A; Rizzo R; Mancuso K; Rocchi S; Pezzi A; Borsi E; Terragna C; Marzocchi G; Santoro A; Cavo M
    Am J Hematol; 2015 Jul; 90(7):647-52. PubMed ID: 25858483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.